Skip to content
Precision for Medicine
Contact Us
Press Release

Precision Continues Asia-Pacific Expansion with Opening of Japan Office

Read More
Shanghai, China skyline

Thursday, May 14 - Saturday, May 16, 2026

DIA China Conference 2026

Booth #F33

Accelerating China‑Driven Innovation for the World

 

Precision for Medicine is proud to join the DIA China Annual Meeting with a strong delegation of scientific, operational, and regulatory experts committed to accelerating innovation across the region. 

For Chinese biotechs aiming to bring breakthrough therapies to global markets, Precision  delivers the expertise and infrastructure to scale with confidence. Our teams seamlessly bridge regional and global requirements, designing programs built for worldwide approvals and powered by harmonized quality systems, multi‑omic analytics, biospecimen solutions, and global clinical operations. Visit us at DIA China to meet with our ex‑FDA, clinical, and operational experts and explore how we can accelerate your path from discovery to global impact.

 

Meet our experts at Booth #F33, or schedule a dedicated meeting using the form below. Look forward to meeting you in Shanghai. 

  • Harpreet Singh-1

    Harpreet Singh, MD

    Chief Medical Officer

    (SizeLimitingPyList: [linkedin])
  • Jing Ping Yeo, PHD, MBA

    Jing Ping Yeo, PhD, MBA

    Vice President, Clinical Operations & Head, Asia Pacific

    (SizeLimitingPyList: [linkedin])
  • James Cheong

    James Cheong

    Senior Vice President, Asia Pacific, Clinical Solutions

    (SizeLimitingPyList: [linkedin])
  • Zhenfei Yin higher resolution

    Zhenfei Yin, MM

    China Country Manager & Senior Director, Project Management

    (SizeLimitingPyList: [linkedin])
  • Sean Hart

    Sean Hart

    Senior Advisor, APAC Business Solutions

    (SizeLimitingPyList: [linkedin])
  • Shanshan Guan

    Shanshan Guan

    Director, Business Development

    (SizeLimitingPyList: [linkedin])

Multiregional Oncology Trials: Practical Guidance from a Former Regulator

Multiregional clinical trials (MRCTs) are now critical for oncology sponsors pursuing efficient global development. Yet they demand a careful balance of scientific rigor, geographic representation, and varying regulatory requirements.

In this whitepaper, a former FDA Oncology Division Director and Precision’s CMO, Dr. Harpreet Singh, share clear, practical guidance on what makes MRCTs truly registration‑ready, so you can streamline global submissions and speed patient access to innovative therapies.

 
Whitepaper

Beyond Geography: A Former Regulator’s Perspective on Multiregional Oncology Trials

Beyond Geography: A Former Regulator’s Perspective on Multiregional Oncology Trials

Meet our team! 

Contact us using the form below. Our team will reach out and set up a meeting time at this year's DIA China Annual Meeting.

Curated Insights

 Deep therapeutic expertise with global regulatory intelligence, ensuring innovative therapies are positioned for successful international submissions and commercialization.
 

 Explore Resources